Get started
Author

Suvendu Giri

ORCID: 0000-0002-7595-1359
Observed ORCID: 0000-0002-7595-1359
OpenAlex ID: A5031229155
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2022 · Ashish Noronha, Nishanth Belugali Nataraj, et al. · Cancer Discovery · 109
PDF
Green Synthesis of Silver Nanoparticles Using the Leaf Extract of the Medicinal Plant, Uvaria narum and Its Antibacterial, Antiangiogenic, Anticancer and Catalytic Properties
2023 · Anthyalam Parambil Ajaykumar, Anjaly Mathew, et al. · Antibiotics · 88
PDF
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib
2024 · Arturo Simoni-Nieves, Moshit Lindzen, et al. · Cell Reports Medicine · 17
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
2023 · Ilaria Marrocco, Suvendu Giri, et al. · Cell Reports Medicine · 16
PDF
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors
2021 · Yuya Haga, Ilaria Marrocco, et al. · Cancer Research · 15
PDF
Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients
2018 · Suvendu Giri, Jagadesh Chandra Bose, et al. · Cardiovascular Toxicology · 15
Repurposing of thalidomide and its derivatives for the treatment of SARS‐coV‐2 infections: Hints on molecular action
2021 · Lakshmikirupa Sundaresan, Suvendu Giri, et al. · British Journal of Clinical Pharmacology · 14
PDF
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse
2025 · Diana Drago-Garcia, Suvendu Giri, et al. · Science Signaling · 9
A proteome-wide systems toxicological approach deciphers the interaction network of chemotherapeutic drugs in the cardiovascular milieu
2018 · Suvendu Giri, Jeganathan Manivannan, et al. · RSC Advances · 5
PDF
Therapeutic Prospects of Nitric Oxide as an Anti-teratogen
2023 · Palanivel Gajalakshmi, Pavitra Kumar, et al. · Advances in biochemistry in health and disease · 4
Breast cancer drugs perturb fundamental vascular functions of endothelial cells by attenuating protein S‐nitrosylation
2019 · Suvendu Giri, Yash Tushar Katakia, et al. · Clinical and Experimental Pharmacology and Physiology · 4
Inhibitors of Nitric Oxide Synthase: What’s up and What’s Next?
2015 · Lakshmikirupa Sundaresan, Suvendu Giri, et al. · Current Enzyme Inhibition · 4
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy
2025 · Rishita Chatterjee, Arturo Simoni-Nieves, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications
2025 · Arunachalam Sekar, Rishita Chatterjee, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2023 · Ashish Noronha, Nishanth Belugali Nataraj, et al. · 1
Regulation of Oxidative Stress by Nitric Oxide Defines Lung Development and Diseases
2019 · Suvendu Giri, Sumukh Thakar, et al. · Springer eBooks · 1
Fc‐Dependent Targeting of the GAS6–MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21
2026 · Suvendu Giri, Boobash Raj Selvadurai, et al. · Advanced Science
PDF
Neuroendocrine-like/EMT dedifferentiation mediates resistance to EGFR inhibitors via the NRG1/HER3 axis
2026 · Alessandra Morselli, Chiara Miroglio, et al. · bioRxiv (Cold Spring Harbor Laboratory)
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens
2026 · Arunachalam Sekar, Boobash Raj Selvadurai, et al. · EMBO Molecular Medicine
PDF
Co-targeting MERTK and EGFR with a Bispecific Antibody Overcomes Drug Resistance Across Mutations in Exons 19, 20, and 21
2025 · Suvendu Giri, Boobash-Raj Selvadurai, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Inducible re-epithelialization of cancer cells increases autophagy and DNA damage: implications for breast cancer dormancy
2025 · Diana Drago Garcia, Suvendu Giri, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2023 · Ashish Noronha, Nishanth Belugali Nataraj, et al.
Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2023 · Ashish Noronha, Nishanth Belugali Nataraj, et al.
Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2023 · Ashish Noronha, Nishanth Belugali Nataraj, et al.
Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
2023 · Ashish Noronha, Nishanth Belugali Nataraj, et al.
Works count: 42
Citation count: 304
H-index: 8
I10-index: 7
Year
Topic
Type